Grid view List view

Showing all 4 results

POM
View product

LetiFend®: vaccine against canine leishmaniasis

Vaccines are not sold to the general public.
They can only be administered by a Veterinarian following a thorough examination of the animal.
Indications for use, specifying the target species

LetiFend®: vaccine against canine leishmaniasis

Safety : Excellent tolerability shown in a wide range of breeds and ages.

Convenience: A single annual dose confers immunity for 365 days.

Reliability: Specific immune response to vaccination that does not interfere with the serological diagnosis of the disease.
LetiFend® reduces the risk of developing clinical leishmaniasis

A dog vaccinated with LetiFend® presents:

 

LetiFend® benefits

More information can be found on the following link: www.noahcompendium.co.uk/Letifend

Nobivac Rabies Cat and Dog
POM
View product

Nobivac Rabies Cat&Dog

Vaccines are not sold to the general public.
They can only be administered by a Veterinarian following a thorough examination of the animal.
Indications for use, specifying the target species
For the active immunisation against rabies to reduce clinical signs and mortality.
Onset of immunity: an adequate serological response (≥ 0.5 I.U.) has been demonstrated 2 to 3 weeks after vaccination.
Duration of immunity: 3 years.
Contraindications
Do not use in unhealthy animals. The vaccine may not be effective in animals incubating the disease at the time of vaccination.
Primary course and booster vaccination
Dogs & cats
Primary vaccination age* 12 weeks or older
Booster vaccination every 3 years
Route of administration intramuscularly or subcutaneously
* Primary vaccination may be administered at an earlier age (minimum in dogs and cats of 4 weeks of age), but then a repeat vaccination must be given at the age of 12 weeks.
Nobivac Tricat Trio
POM
View product

Nobivac Tricat Trio Cat

Vaccines are not sold to the general public.
They can only be administered by a Veterinarian following a thorough examination of the animal.

Nobivac® Tricat Trio is a live attenuated, freeze-dried vaccine containing the 3 core viruses – feline panleucopaenia virus, feline herpesvirus, and feline calicivirus.

Core feline vaccination
Vaccination is an integral part of a preventative health care programme. Every cat should be vaccinated against 3 core diseases – feline panleucopaenia (or infectious enteritis), feline herpesvirus and feline calicivirus (both causes of “cat flu”). These diseases can have devastating consequences for a cat and it is easy to prevent them by regular vaccination.

Active Ingredients
A live attenuated freeze dried vaccine containing feline herpes virus type 1 (rhinotracheitis), feline calicivirus and feline panleucopaenia virus (MW-1).

Indications
For the active immunisation of cats against feline panleucopaenia virus (FPLV), feline herpes virus (FHV) and feline calicivirus (FCV). Vaccination will reduce clinical signs caused by infection with FHV and FCV; reduce replication of FCV, and prevent shedding of FPLV.

  • The duration of immunity is 3 years for the FCV, FHV and FPLV components, as confirmed by challenge study.

Dosage
The contents of one vial of reconstituted vaccine should be injected subcutaneously. Reconstitute immediately prior to use by addition of one vial of Nobivac Diluent.

For an initial vaccination, two doses are required, at an interval of 3 to 4 weeks. The first inoculation is given from the age of 8-9 weeks and the second inoculation from the age of 12 weeks. If earlier vaccination if desirable or necessary, vaccination is appropriate from 6 weeks of age onwards, but should be followed by the normal vaccination scheme at 8-9 and 12 weeks of age.

Revaccination
A single dose. Recommended revaccination following initial programme:

  • FCV, FHV and FPLV revaccinate three-yearly.
  • For cats exposed to high-risk environments, annual revaccination should be considered.
Versifel FeLV
POM
View product

Versifel FeLv Cat

Vaccines are not sold to the general public.
They can only be administered by a Veterinarian following a thorough examination of the animal.

 

For active immunization of susceptible cats from 9 weeks of age to reduce the number of cats infected with FeLV and presenting clinical signs of the related disease. No data are available in the studies to demonstrate protection against related clinicaldisease but prevention of infection is associated with protection against related clinical disease.
Onset of immunity occurs within four weeks of the completion of the primary vaccination course.

The duration of immunity is at least one year after the primary course and three years after the booster.

Only healthy animals should be vaccinated.
Do not vaccinate FeLV antigen positive cats.
Therefore a test for presence of FeLV before vaccination is recommended.